Oxford Asset Management’s Terns Pharmaceuticals TERN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-33,027	Closed	-$91.2K	–	733
2025 Q1	$91.2K	Buy	33,027 +17,571	+114%	+$48.5K	0.04%	414
2024 Q4	$85.6K	Buy	+15,456	New	+$85.6K	0.04%	399
2024 Q3	–	Sell	-14,689	Closed	-$100K	–	441
2024 Q2	$100K	Buy	+14,689	New	+$100K	0.1%	231